Skip to main content
Provide your raw performance data or summary statistics alongside the applicable CLSI or ICSH guideline. Anara writes the discussion section interpreting the results in clinical context, identifying any parameters outside acceptable limits, and citing the guideline criteria throughout. For clinical laboratory scientists and point-of-care coordinators producing regulatory-grade validation documentation.

​
1. Describe the task

You have run the validation study. You have the data: Bland-Altman comparison, coefficient of variation, Deming regression, commutability results. What you need is the written discussion section that interprets these results in clinical context, against the applicable guideline criteria, and in language appropriate for a regulatory-grade laboratory validation report. Writing that section from raw statistics takes significant time: translating performance metrics into clinical language, mapping each result against the CLSI EP09 or EP15 criteria, characterizing what falls within acceptable limits and what does not. Anara can draft the section for you. You provide the data, the applicable guideline, and the analyzers being compared. Anara interprets the statistics against the guideline criteria, writes the discussion in formal laboratory reporting language, and flags any parameter outside the acceptable range. The statistical accuracy of the input data is yours to verify. Anara interprets and writes from the data you provide; it does not reanalyze your raw data or recalculate your statistics. The discussion draft reflects the interpretation of the numbers you supply. Here a clinical laboratory scientist is validating a new haemoglobin analyzer against the laboratory’s current reference instrument and needs the discussion section for the validation report. 
I am writing the discussion section of a laboratory validation report comparing haemoglobin measurement on Analyzer B versus our reference Analyzer A. I have attached the following: (1) a summary of our raw data and statistical analysis including Bland-Altman bias, limits of agreement, Deming regression slope and intercept, and coefficient of variation results; (2) the applicable CLSI EP09-A3 guideline.

Write a discussion section for the laboratory validation report covering:
- Summary of the Bland-Altman bias and limits of agreement, interpreted against the guideline's acceptable bias criteria
- Deming regression findings and what the slope and intercept indicate about the relationship between the two analyzers
- Coefficient of variation results, interpreted against acceptable imprecision criteria
- Whether the overall performance supports validation of Analyzer B as a replacement for Analyzer A
- Any parameters outside acceptable limits, stated explicitly with the specific guideline criterion they fail

Use formal laboratory report language throughout. Reference the applicable CLSI EP09-A3 criteria by section for each interpretive statement.

​
2. Give Anara context

Required context
  • Your performance data summary or raw results, either attached or pasted into the chat.
  • The applicable guideline or standard (CLSI EP09, CLSI EP15, ICSH, ISO 17025). Attach the relevant sections or note which guideline applies.
Optional context
  • A completed example discussion section from a prior validation report. Anara matches the formal language conventions your laboratory uses.
  • The clinical context for the analyte being validated. For example, whether the analyte is used for diagnostic decisions versus monitoring, which affects how tightly the bias and imprecision criteria apply.

​
3. What Anara creates

A formal discussion section covering each performance dimension you specified, interpreting results against the guideline criteria with named section references. Parameters within acceptable limits are characterized as meeting criteria. Parameters outside acceptable limits are named explicitly and the failing criterion is stated. The section is written in the formal language appropriate for a regulatory-grade laboratory validation document. You review the interpretation, verify it against your data tables, and file the section.

​
4. Follow-up prompts

​
Write the conclusions section

When the discussion is complete and you need the formal conclusions to follow it. 
Based on the discussion section you just wrote, draft the conclusions section for the validation report. State whether Analyzer B is validated for clinical use as a replacement for Analyzer A, with a one-sentence justification for each performance dimension assessed.

​
Interpret a specific parameter more deeply

When one result needs a more detailed clinical interpretation than the main discussion provides. 
The limits of agreement for haemoglobin are wider than the guideline threshold. Write an additional paragraph interpreting the clinical significance of this finding: under what clinical circumstances would this level of agreement be acceptable, and under what circumstances would it require re-evaluation?

​
Adapt the discussion for a second analyte from the same study

When the same validation run covered multiple analytes. 
The same validation run also assessed mean corpuscular volume. Here are the MCV statistics: [paste statistics]. Apply the same discussion structure to MCV, using the same guideline and the same formal report language.

​
5. Tricks, tips, and troubleshooting

​
How you word your prompt shapes what you get

Name the specific guideline and section numbers you want cited in the discussion. “CLSI EP09-A3” is more useful than “the applicable CLSI guideline” because it tells Anara exactly which document’s criteria to apply for bias and regression interpretation. If your validation includes multiple performance tests from different guidelines (for example, EP09 for method comparison and EP15 for precision), list both in the prompt so the discussion applies the correct criteria to each section. Asking for parameters outside acceptable limits to be stated explicitly rather than hedged prevents the kind of softened language that can fail on regulatory review.

​
Check the output against your own understanding

Read the interpretation against your own data tables before filing the section. Anara writes from the summary statistics you provide; if your summary contains a calculation error or a mislabeled result, the discussion will reflect that error. The interpretation of whether a result is within or outside acceptable limits is a clinical laboratory judgment that your laboratory’s quality manager must confirm. The draft is a starting point for the discussion, not a regulatory determination.

​
What to do with the output next

Integrate the discussion section into the full validation report document, following your laboratory’s standard format. Have the section reviewed by the laboratory director or quality manager before the report is finalized. If the discussion identifies parameters outside acceptable limits, the report needs a formal plan for addressing those findings before Analyzer B is released for clinical use.